Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents
Article in Frontiers in Pharmacology (June 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
Article in Frontiers in Pharmacology (June 2022)
A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
Article in Frontiers in Psychiatry (January 2022)